Rapid multiplex PCR was the most costly, yet effective strategy for detecting influenza among a cohort of children aged 3 months to 18 years presenting to an ED with influenza-like illness, according ...
May 25, 2010 — The US Food and Drug Administration (FDA) has issued 510(k) clearance to a new influenza test (Simplexa Influenza A H1N1 [2009] test; Quest Diagnostics Incorporated), making it the ...